Clinical Trial: Vaginal Progesterone for Treatment of Threatened Miscarriage
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Vaginal Progesterone for Treatment of Threatened Miscarriage; Randomized Clinical Trial
Brief Summary: The purpose of the study is to assess the efficacy of vaginal micronized progesterone in the treatment of threatened miscarriage. All eligible pregnant women will be randomized to either receive vaginal progesterone or no treatment.Evaluation will be two weeks after intervention, then every 4 weeks up to 28 weeks gestation or termination of pregnancy.
Detailed Summary:
Sponsor: Omar Mamdouh Shaaban
Current Primary Outcome: Miscarriage rate up to 28 weeks of gestation [ Time Frame: Completed 28th week ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Gestational age at delivery or termination of pregnancy [ Time Frame: Number of completed weeks at the time of delivery ]
Original Secondary Outcome: Same as current
Information By: Assiut University
Dates:
Date Received: February 19, 2016
Date Started: February 2016
Date Completion: February 2018
Last Updated: February 23, 2016
Last Verified: February 2016